Urgent.News

600+ sources. One page. See who else covered it.

Editions

Business

Khartis Therapeutics Raises $50M To Advance Oral Immunology Drugs

Khartis Therapeutics Raises $50M Series B Khartis Therapeutics has raised $50 million in Series B funding to advance its oral medicine pipeline.mForge Life Science Partners led the round. Longwood Fund The post Khartis Therapeutics Raises $50M To Advance Oral Immunology Drugs appeared first on Ventureburn .

Khartis Therapeutics Raises $50M To Advance Oral Immunology Drugs

We haven't written up this one. Ventureburn has the full story — the link below goes straight to it.

Read the original at ventureburn.com →

More in Business

More from Thursday 13 August →